Quantitative Systematic Strategies LLC Biogen Inc. Transaction History

Quantitative Systematic Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $734,925 - $958,422	-2,597 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $40,404 - $64,694	-156 Reduced 5.67%	2,597 $899,000
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $4,373 - $5,123	18 Added 0.66%	2,753 $770,000
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $39,691 - $59,745	-168 Reduced 5.79%	2,735 $670,000
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $259,209 - $299,290	979 Added 50.88%	2,903 $824,000
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $311,685 - $412,772	1,205 Added 167.59%	1,924 $515,000
Q1 2020 May 06, 2020	SELL	$268.85 - $341.04 $870,536 - $1.1 Million	-3,238 Reduced 81.83%	719 $227,000
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $870,777 - $1.2 Million	3,957 New	3,957 $1.17 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.